Fingerprint
Dive into the research topics of 'TROPiCS-02: A Phase III study investigating sacituzumab govitecan in the treatment of HR+/HER2-metastatic breast cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
TROPiCS-02: A Phase III study investigating sacituzumab govitecan in the treatment of HR+/HER2-metastatic breast cancer
Hope S. Rugo, Aditya Bardia, Sara M. Tolaney, Carlos Arteaga, Javier Cortes, Joohyuk Sohn, Frederik Marmé, Quan Hong, Rosemary J. Delaney, Amir Hafeez, Fabrice André, Peter Schmid
Research output: Contribution to journal › Article › peer-review
75
Scopus
citations